Enteral nutrition supplemented with l-glutamine in patients with systemic inflammatory response syndrome due to pulmonary infection

Nutrition

Volumn 28, Issue 4, 2012, Pages 397-402

  Cavalcante, Ana Augusta Monteiro ^a   Campelo, Márcio Wilker Soares ^a   De Vasconcelos, Marcelo Pinho Pessoa ^a   Ferreira, Camila Marques ^a   Guimarães, Sergio Botelho ^a   Garcia, José Huygens Parente ^a   De Vasconcelos, Paulo Roberto Leitão ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Glutamine; Glutathione; Lipid peroxidation; Oxidative stress; Sepsis; Thiobarbituric acid reactive substances

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; CALCIUM CASEINATE; CALCIUM DERIVATIVE; CYSTEINE; CYTOKINE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCINE; HISTIDINE; ISOLEUCINE; LYSINE; METHIONINE; NUTRACEUTICAL; PHENYLALANINE; PROLINE; SERINE; THREONINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; UREA; VALINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FEMALE; HEMATOCRIT; HUMAN; IMMUNE SYSTEM; INSULIN RESISTANCE; LEUKOCYTE COUNT; LIPID PEROXIDATION; LUNG INFECTION; LYMPHOCYTE COUNT; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UREA BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; CASEINS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FEMALE; GLUTAMINE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UREA;

EID: 84858292112     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.07.011     Document Type: Article

References (26)

1. Novak F., Heyland D.K., Avenell A., Drover J.W., Su X. Glutamine supplementation in serius illness: a systematic review of the evidence. Crit Care Med 2002, 3:2022-2029.
2. Fuentes-Orozco C., Anaya-Prado R., González-Ojeda A., Arenas-Márquez H., Cabrera-Privaral C., Cervantes-Guevara G., Barrera-Zepeda L. L-Alanyl-l-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr 2004, 23:13-21.
3. Ziegler T.R., Ogden L.G., Singleton K.D., Luo M., Fernandez-Estivariz C., Griffith D.P., et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005, 31:1079-1086.
4. Abilés J., Moreno-Torres R., Moratalla G., Castaño J., Abúd R.P., Mudarra A., et al. Efectos de la suplementación con glutamina sobre el sistema antioxidante y la peroxidación lipídica en pacientes críticos con nutrición parenteral. Nutr Hosp 2008, 23:332-339.
5. Dechelotte P., Hasselmann M., Cynober L., Allaouchiche B., Coëffier M., Hecketsweiler B., et al. l-Alanyl-l-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 2006, 34:598-604.
6. Bakalar B., Duska F., Pachl J., Fric M., Otahal M., Pazout J., Andel M. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006, 34:381-386.
7. Cetinbas F., Yelken B., Gulbas Z. Role of glutamine administration on cellular immunity after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome. J Crit Care 2010, 25:661. e1-e6.
8. Cynober L. Les pharmaconutrients azotes: du tube à essai à la pratique clinique. Nutr Clin Metab 2001, 15:131-143.
9. Garcia-de-Lorenzo A., Zarazaga A., Garcia-Luna P.P., Gonzalez-Huix F., López-Martínez J., Miján A., et al. Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition 2003, 19:805-811.
10. Heyland D.K., Dhaliwal M.R., Day A., Drover J., Cote H., Wischmeyer P. Dose-finding study optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. JPEN 2007, 31:109-118.
11. Schulman A.S., Willcutts K.F., Claridge J.A., Evans H.L., Radigan A.E., O'Donnell K.B., et al. Does the addition of glutamine to enteral feeds affect patient mortality?. Crit Care Med 2005, 33:2501-2506.
12. Laboratório de Epidemiologia e Estatística do Instituto Dante Pazzanese. Disponível no. Available at: Accessed July 18, 2010. http://www.lee.dante.br.
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 6:1644-1655.
14. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification. Crit Care Med 1985, 13:818-829.
15. Fürst P., Alteheld B., Stehle P. Why should a single nutrient-glutamine-improve outcome? The remarkable story of glutamine dipeptides. Clin Nutr Suppl 2004, 1:3-15.
16. Tietz N.W. Clinical guide on clinical laboratory tests 1991, AACC Press, Washington, DC. 4th ed.
17. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969, 6:24-27.
18. Burtis C.A., Ashwood E.R. Tietz textbook of clinical chemistry 1994, WB Saunders, Philadelphia. 2nd ed.
19. Coëffier M., Tamion F., Déchelotte P. Supplémentation parentérale en glutamine en réanimation: preuves cliniques et mecanismes d'action. Reanimation 2009, 18:506-510.
20. Hall J.C., Dobb G., Hall J., Sousa R., Brennan L., McCauley R. A prospective randomized trial of enteral in critical illness. Intensive Care Med 2003, 29:1710-1716.
21. Grimble R.F. Nutritional modulation of immune function. Proc Nutr Soc 2001, 60:389-397.
22. Galera S.C., Fechine F.V., Teixeira M.J., Coelho Z.C.B., Vasconcelos R.C., Vasconcelos P.R.L. The safety of oral use of l-glutamine in middle-aged and elderly individuals. Nutrition 2010, 26:375-381.
23. Heyland D.K., Dhaliwal R., Day A.G., Muscedere J., Drover J., Suchner U., et al. Canadian Critical Care Trials Group. Reducing deaths due to oxidative stress (the REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 2006, 65:250-263.
24. Amores-Sánchez M.I., Medina M.A. Glutamine, as a precursor of glutathione, and stress oxidative. Mol Genet Metab 1999, 67:100-105.
25. Alves W.F., Aguiar E.E., Guimarães S.B., Filho A.R.S., Pinheiro P.M.A., Soares D.S.D., Vasconcelos P.R.L. l-Alanyl-glutamine preoperative infusion in patients with critical limb ischemia subjected to distal revascularization reduces tissue damage and protects from oxidative stress. Ann Vasc Surg 2010, 24:461-467.
26. Houdijk A.P.J., Rijnsburger E.R., Janse J., Wesdorp R.I.C., Weiss J.K., Mccamish M.A., et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998, 352:1-5.